GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
150
c/glp1eu·posted 7 months ago by u/milan_mensah

[Question] the UK — has anyone got a straight answer on reimbursement

Question

the UK — has anyone got a straight answer on reimbursement, and I want the answer with the reasoning attached rather than just the conclusion.

The structure that makes this board make sense, once.

Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.

So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.

Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested.

The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.

I will update this if the picture changes rather than quietly leaving it up.

211 up / 61 down77% upvoted13 commentsid 1062n520 Dec 2025

13 comments

13 in this archive, depth 4

best — the order this archive was captured in

u/rt_shift_reggie21 points·7 months ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/sten_bhattacharya17 points·7 months ago

Supply notices are issued nationally.

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/fabio_ibarra0 points·7 months ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/wanjiru_ramos7 points·7 months ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/nikhil_asante3 points·7 months ago

Have you read the published reimbursement criteria where you are?

replysharereportpermalink
u/kaplan_meier_kim4 points·7 months ago·edited

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/gastric_emptying_g2 points·7 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/marisol_kravchenko20 points·7 months ago·edited

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/dario_petrescu13 points·7 months ago·edited

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/naomi_erdogan13 points·7 months ago·edited

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/rt_shift_reggie9 points·7 months ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink
u/cormac_erdogan7 points·7 months ago

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
load more comments (1) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.